Sjogren's Syndrome Clinical Trials 2022

Browse 14 Sjogrens Syndrome Medical Studies Across 129 Cities

1 Phase 3 Trial · 210 Sjogrens Syndrome Clinics

Reviewed by Michael Gill, B. Sc.
14 Sjogrens Syndrome Clinical Trials Near Me
Omaha, NE
Brandon, FL
Iowa City, IA
Fullerton, CA
More Trial Locations
An interactive map to display trial locations for University of Nebraska Medical Center, Bay Area Arthritis and Osteoporosis, University of Iowa Hospitals and Clinics, St. Jude Heritage Medical Group, and 123 more locations.
Top Hospitals for Sjogrens Syndrome Clinical Trials
Location
Active Sjogrens Syndrome Clinical Trials
All Time Trials for Sjogrens Syndrome
First Recorded Sjogrens Syndrome Trial
Trials
West Tennessee Research Institute, Jackson, Tennessee
2
4
2016
PMG Research of Salisbury, Salisbury, North Carolina
2
3
2017
Novartis Investigative Site, Rimouski, Quebec
2
2
2019
Novartis Investigative Site, Toronto, Ontario
2
2
2019
Top Treatments for Sjogrens Syndrome Clinical Trials
Treatment Name
Active Sjogrens Syndrome Clinical Trials
All Time Trials for Sjogrens Syndrome
First Recorded Sjogrens Syndrome Trial
Trials
Cyclosporine 0.09% Ophthalmic Solution
1
1
2021
Tivanisiran sodium ophthalmic solution
1
1
2021
Top Cities for Sjogrens Syndrome Clinical Trials
City
Active Sjogrens Syndrome Clinical Trials
Top Active Site for Sjogrens Syndrome Clinical Trials
Trial List
Which phases are most popular for sjogren's syndrome clinical trials?
How many sjogren's syndrome clinical trials are open to youth and / or seniors?
Phase 3 Sjogrens Syndrome Clinical Trials
Clinical Trial
Began Recruiting Date
Phase
Senior Friendly Sjogrens Syndrome Clinical Trials
Recently Completed Studies with FDA Approved Treatments for Sjogrens Syndrome
Treatment
Year
Mechanism of Action
Sponsor
Active Sjogrens Syndrome Clinical Trials
LOU064
2019
Novartis Pharmaceuticals
0

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 29th, 2021

Last Reviewed: August 15th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.